Fig 1: Soluble CD226, CD112 and CD155 molecule levels throughout pregnancy and in non-pregnant women. The serum concentration of sCD226 (A), sCD112 (B) and sCD155 (C) molecules in women during healthy pregnancy and in non-pregnant women. The solid bars represent medians, the boxes indicate the interquartile ranges, and the lines show the most extreme observations.
Fig 2: CD155 and CD112 receptor expression by different immune cell subpopulations throughout pregnancy and in non-pregnant women. Significant differences in the expression of CD155 molecule by NKT- (A), classical monocyte (B) subpopulation and CD112 expression by NKdim (C) cell subset in the peripheral blood during healthy pregnancy and in non-pregnant women. The solid bars represent medians, the boxes indicate the interquartile ranges, and the lines show the most extreme observations. Differences were considered statistically significant for p-values <0.03 **.
Fig 3: Possible interactions among TIGIT and CD226 surface receptors with CD112 and CD155 nectin and nectin-like molecules. TIGIT and CD226 receptors are primarily expressed on the surface of both T- and NK cells. After interacting with their ligands (CD155, CD112), TIGIT transmits inhibitory signals while CD226 delivers stimulatory signals in the effector cells. The two-sided arrows indicate the possible connections and are proportional to the binding affinities.
Fig 4: CD112 and CD155 ligand expression by different NKT cell subpopulations in EOP and healthy pregnancy. CD112 (A) and CD155 ligand expression (B) by the CD8 and CD4 surface molecule positive and negative NKT cell subpopulations in EOP patients and healthy pregnant women. The solid bars represent medians of 16, 16, 17 and 17 determinations, respectively. The boxes indicate the interquartile ranges, and the whiskers show the most extreme observations. The middle square within the box represents the mean value. Significant differences with p-values < 0.01 ***, <0.03 ** and <0.05 * are indicated. Representative FACS plots show the CD112 surface marker (C) and CD155 surface molecule (D) expression by cells in the lymphocyte gate. FMO control was used to determine CD112 and CD155 expression.
Supplier Page from Thermo Fisher Scientific for Human Nectin-2/CD112 ELISA Kit